Table 3
DLQI scores in study group at baseline and after 12 weeks of regular treatment.
| | Type of study subjects | Pretreatment (baseline) | Posttreatment (after 12 weeks) | value |
| | Total cases ( = 40) | 14.45 ± 3.19 | 9.40 ± 6.52 | 0.0004 | | Patients having lesions at mixed sites ( = 8) | 14.27 ± 2.66 | 8.33 ± 4.87 | 0.0001 | | Patients with lesions at unexposed sites ( = 32) | 14.20 ± 5.01 | 11.20 ± 7.73 | 0.0587 | | Patients who achieved ≥75% PASI improvement ( = 8) | 12.25 ± 3.06 | 4.00 ± 2.73 | 0.0001 | | Patients who achieved 50–75% PASI improvement ( = 16) | 13.38 ± 2.83 | 5.75 ± 1.24 | 0.0001 | | Patients with <50% PASI improvement ( = 12) | 16.5 ± 2.39 | 14.67 ± 4.41 | 0.1737 | | Patients reporting worsening of disease ( = 4) | 16.00 ± 2.31 | 19.75 ± 2.63 | 0.0006 |
|
|
